• ebola virus

    New laboratory study of five ebola vaccines provides data on features and functions of vaccine protection

    A new study published in Science Translational Medicine reports on the Ebola vaccine-mediated protection of five mucosal vaccine vectors based on the human and avian paramyxoviruses. The study comprehensively characterized the antibody response to each vaccine, identifying features and functions that were elevated in survivors and that could serve as vaccine correlates of protection.

  • heart health illustration

    Statins can save lives only if patients take them

    When John Davis collapsed on the basketball court, he knew he could have prevented it. He could have avoided the heart attack, the trip to the ER and the need for a stent to allow blood to once again flow freely from his heart to the rest of his body. Davis was healthy and in his twenties when doctors diagnosed him with a genetic condition that required him to take medication to lower his cholesterol. These medications, commonly known as statins, help patients avoid heart attacks and strokes by reducing bad cholesterol levels. They are some of the most commonly prescribed medications in the U.S.

  • Covid virus image

    SARS-CoV-2 can infect testes, UTMB researchers find

    Researchers at the University of Texas Medical Branch have found SARS-CoV-2, the virus that causes COVID-19, in the testes of infected hamsters. The findings, published in the journal Microorganisms, could help explain symptoms that some men with COVID-19 have reported and have important implications for men’s health.

  • widescreen rendering of JohnSealy Hospital

    Ribbon-cutting for renovated John Sealy Tower

    The long-awaited renovation of the AB wing of John Sealy Hospital at the University of Texas Medical Branch Galveston Campus will mark its completion with a ribbon-cutting ceremony on June 3. Approximately 220,000 square feet were renovated across five different floors, which will house services for women, infants and children.

  • ebola virus

    UTMB scientists awarded $11.3 million for new studies on Ebola virus

    Researchers at the University of Texas Medical Branch at Galveston have been awarded an $11.3 Million, multi-year grant from the National Institute of Allergy and Infectious Diseases to study immunopathogenesis of Ebola, and in particular to determine why cells infected with Ebola develop “immune system paralysis,” which inhibits immune response leads to hyper inflammation and allows the deadly infection to spread. The research will be led by Co-Principal Investigators Alexander Bukreyev, PhD., of UTMB’s Department of Pathology, and Mariano Garcia-Blanco, MD, PhD, Chair of the Biochemistry and Molecular Biology Department.

  • New study looks at long-term outcomes and costs of high-risk non-muscle invasive bladder cancer treatment

    A new research study leveraging a database from the largest equal access health system in the US, the Department of Veteran Affairs offers insight into the outcome of specific treatment patterns for advanced bladder cancer patients. Lead author Dr. Stephen Williams of the University of Texas Medical Branch says it is one of the first comprehensive studies looking at both the outcomes and the costs of treating a potentially lethal and devastating type of bladder cancer.

  • Combination Therapy Protects Against Advanced Marburg Virus Disease

    A new study conducted at the Galveston National Laboratory at The University of Texas Medical Branch at Galveston (UTMB) has shown substantial benefit to combining monoclonal antibodies and the antiviral remdesivir against advanced Marburg virus. The study was published today in Nature Communications.